{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:47:58Z","timestamp":1759366078182,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaad.2022.12.055","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T16:52:06Z","timestamp":1676047926000},"page":"e219-e220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The limits of claims databases: A response to \u201cA comparison of invasive squamous cell carcinoma greater than 1\u00a0year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid\u201d"],"prefix":"10.1016","volume":"89","author":[{"given":"Joshua","family":"Hackney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Swerlick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Muir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jaad.2022.12.055_bib1","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/jid.2013.134","article-title":"Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study","volume":"133","author":"Flohil","year":"2013","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.12.055_bib2","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaad.2016.08.027","article-title":"Sex differences in the association of cutaneous melanoma incidence rates and geographic ultraviolet light exposure","volume":"76","author":"Liu-Smith","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.12.055_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/phpp.12139","article-title":"The relationship between UV exposure and incidence of skin cancer","volume":"31","author":"Moan","year":"2015","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"2","key":"10.1016\/j.jaad.2022.12.055_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14833","article-title":"Patient-reported outcomes of topical therapies in actinic keratosis: a systematic review","volume":"34","author":"Grada","year":"2021","journal-title":"Dermatol Ther"},{"issue":"3","key":"10.1016\/j.jaad.2022.12.055_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jid.2016.10.019","article-title":"Surgery versus 5% imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial","volume":"137","author":"Williams","year":"2017","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222300186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222300186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:28:41Z","timestamp":1759274921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222300186X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S019096222300186X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.12.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The limits of claims databases: A response to \u201cA comparison of invasive squamous cell carcinoma greater than 1\u00a0year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid\u201d","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.12.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}